Valneva begins clinical trials for inactivated, adjuvanted COVID-19 vaccine,

December 16, 2020 — Valneva has begun a phase I/II clinical trial to study its inactivated, adjuvanted COVID-19 vaccine candidate, VLA2001., December 16, 2020 — Valneva has begun a phase I/II clinical trial to study its inactivated, adjuvanted COVID-19 vaccine candidate, VLA2001., Read More

Scroll to Top